Upload
dinah-manning
View
214
Download
0
Tags:
Embed Size (px)
Citation preview
MOLECULAR MECHANISMS INFLUENCING
THE BIOMARKER LEVELS OF ENVIRONMENTAL
GENOTOXIC EXPOSURE
MOLECULAR MECHANISMS INFLUENCING
THE BIOMARKER LEVELS OF ENVIRONMENTAL
GENOTOXIC EXPOSURE
Bernadette SchoketBernadette Schoket
Department of Molecular Environmental EpidemiologyNational Institute of Environmental Health
József Fodor National Centre for Public HealthBudapest, Hungary
Department of Molecular Environmental EpidemiologyNational Institute of Environmental Health
József Fodor National Centre for Public HealthBudapest, Hungary
IMPORTANT ISSUES IN HUMAN
BIOMONITORING
IMPORTANT ISSUES IN HUMAN
BIOMONITORING
The use of surrogate and target tissues to estimate environmental genotoxic exposure
The modulation of biomarker levels by genetic susceptibility factors
The use of surrogate and target tissues to estimate environmental genotoxic exposure
The modulation of biomarker levels by genetic susceptibility factors
AIMS OF THE STUDYAIMS OF THE STUDY
Correlation between smoking-related bulky
carcinogen-DNA adduct levels in lung tissues
and in peripheral blood lymphocytes
The influence of glutathione S-transferase
metabolic genotypes on the DNA adduct levels
induced by cigarette smoking
Correlation between smoking-related bulky
carcinogen-DNA adduct levels in lung tissues
and in peripheral blood lymphocytes
The influence of glutathione S-transferase
metabolic genotypes on the DNA adduct levels
induced by cigarette smoking
STUDY POPULATIONSTUDY POPULATION Lung cancer patients undergoing lung resection, N = 212 Lung cancer patients undergoing lung resection, N = 212
Normal bronchus
Normal peripheral lung
Peripheral blood lymphocytes
Normal bronchus
Normal peripheral lung
Peripheral blood lymphocytes
SMOKING STATUSSMOKING STATUS
Current Smokers Life-time Non-smokers
& &
Short-term Ex-smokers Long-term Ex-smokers
( 1 year of abstinence ) ( > 1 year of
abstinence )
Current Smokers Life-time Non-smokers
& &
Short-term Ex-smokers Long-term Ex-smokers
( 1 year of abstinence ) ( > 1 year of
abstinence )
‘SMOKERS’ ‘NON-SMOKERS’‘SMOKERS’ ‘NON-SMOKERS’
DETERMINATION OF BULKY CARCINOGEN-DNA ADDUCTS DETERMINATION OF BULKY CARCINOGEN-DNA ADDUCTS
32P-Postlabelling 32P-Postlabelling
METHODOLOGYMETHODOLOGY
DETERMINATION OF GENOTYPES DETERMINATION OF GENOTYPES
PCR and PCR-RFLPPCR and PCR-RFLP
GSTM1GSTT1GSTP1 Ile105Val
GSTM1GSTT1GSTP1 Ile105Val
X
Phase I Phase II
X X
OH O-conj.
DNA damage
BULKY DNA ADDUCTS IN TISSUES FROMCURRENT SMOKER LUNG CANCER PATIENTS
BULKY DNA ADDUCTS IN TISSUES FROMCURRENT SMOKER LUNG CANCER PATIENTS
Lung tumour Normal lung Normal bronchus Blood lymphocytesLung tumour Normal lung Normal bronchus Blood lymphocytes
LEVELS OF BULKY DNA ADDUCTS IN LUNG TISSUES AND PERIPHERAL BLOOD LYMPHOCYTES
LEVELS OF BULKY DNA ADDUCTS IN LUNG TISSUES AND PERIPHERAL BLOOD LYMPHOCYTES
Normal
lung(3
9)
Normal
bro
nchus(3
7)
Lymphocyt
es(25)
Normal
lung(3
2)
Normal
bro
nchus(3
2)
Lymphocyt
es(22)
0
10
20
30
Bu
lky
DN
A a
dd
uc
ts /
10
8 n
uc
leo
tid
es
Smokers Non-smokers
.
Normal
lung(3
9)
Normal
bro
nchus(3
7)
Lymphocyt
es(25)
Normal
lung(3
2)
Normal
bro
nchus(3
2)
Lymphocyt
es(22)
0
10
20
30
Bu
lky
DN
A a
dd
uc
ts /
10
8 n
uc
leo
tid
es
Smokers Non-smokers
.
CORRELATION BETWEEN BULKY DNA ADDUCT LEVELS IN NORMAL PERIPHERAL LUNG
AND BRONCHIAL TISSUES
CORRELATION BETWEEN BULKY DNA ADDUCT LEVELS IN NORMAL PERIPHERAL LUNG
AND BRONCHIAL TISSUES
• Smokers: r=0.83 P<0.0001 (N=38)
• Non-smokers: r=0.73 P<0.0001 (N=30)
• Smokers: r=0.83 P<0.0001 (N=38)
• Non-smokers: r=0.73 P<0.0001 (N=30)
0 10 20 300
10
20
30 n=19r=0.25P=0.30
Smokers
Bulky adducts/108 nucleotides
Normal lung
Blo
od
lym
ph
oc
yte
sB
ulk
y a
dd
ucts
/10
8 n
ucle
oti
des
0 10 20 300
10
20
30 n=17r=0.55P=0.023
Non-smokers
Bulky adducts/108 nucleotides
Normal lung
Blo
od
lym
ph
oc
yte
sB
ulk
y a
dd
ucts
/10
8 nu
cle
oti
des
0 10 20 300
10
20
30 n=19r=0.25P=0.30
Smokers
Bulky adducts/108 nucleotides
Normal lung
Blo
od
lym
ph
oc
yte
sB
ulk
y a
dd
ucts
/10
8 n
ucle
oti
des
0 10 20 300
10
20
30 n=17r=0.55P=0.023
Non-smokers
Bulky adducts/108 nucleotides
Normal lung
Blo
od
lym
ph
oc
yte
sB
ulk
y a
dd
ucts
/10
8 nu
cle
oti
des
0 10 20 300
10
20
30 n=19r=0.31P=0.20
Smokers
Bulky adducts/108 nucleotides
Normal bronchus
Blo
od
lym
ph
oc
yte
s
Bu
lky a
dd
ucts
/10
8 n
ucle
oti
des
0 10 20 300
10
20
30 n=16r=0.55P=0.026
Non-smokers
Bulky adducts/108 nucleotides
Normal bronchus
Blo
od
lym
ph
oc
yte
s
Bu
lky a
dd
ucts
/10
8 n
ucle
oti
des
0 10 20 300
10
20
30 n=19r=0.31P=0.20
Smokers
Bulky adducts/108 nucleotides
Normal bronchus
Blo
od
lym
ph
oc
yte
s
Bu
lky a
dd
ucts
/10
8 n
ucle
oti
des
0 10 20 300
10
20
30 n=16r=0.55P=0.026
Non-smokers
Bulky adducts/108 nucleotides
Normal bronchus
Blo
od
lym
ph
oc
yte
s
Bu
lky a
dd
ucts
/10
8 n
ucle
oti
des
CORRELATION BETWEEN DNA ADDUCT LEVELSIN LUNG TISSUES AND LYMPHOCYTES
CORRELATION BETWEEN DNA ADDUCT LEVELSIN LUNG TISSUES AND LYMPHOCYTES
FOR SMOKERS AND NON-SMOKERSFOR SMOKERS AND NON-SMOKERS
Positiv
e (7
4)
Null (6
6)
Positiv
e (3
1)
Null (4
1)0
10
20
30
DN
A a
dd
uct
s /
108
nu
cleo
tid
es
Positiv
e (1
01)
Null (4
0)
Positiv
e (4
5)
Null (2
6)0
10
20
30
DN
A a
dd
uct
s /
108 n
ucl
eoti
des
Pos&Pos
(46)
Null&Null
(13)
Pos&Pos
(16)
Null&Null
(11)
0
10
20
30P=0.058
DN
A a
dd
uct
s /
108 n
ucl
eoti
des
Positiv
e (7
4)
Null (6
6)
Positiv
e (3
1)
Null (4
1)0
10
20
30
DN
A a
dd
uct
s /
108
nu
cleo
tid
es
Positiv
e (1
01)
Null (4
0)
Positiv
e (4
5)
Null (2
6)0
10
20
30
DN
A a
dd
uct
s /
108 n
ucl
eoti
des
Pos&Pos
(46)
Null&Null
(13)
Pos&Pos
(16)
Null&Null
(11)
0
10
20
30P=0.058
DN
A a
dd
uct
s /
108 n
ucl
eoti
des
GSTM1 AND GSTT1 GENOTYPES AND BULKY DNA ADDUCT LEVELS IN BRONCHUS
GSTM1 AND GSTT1 GENOTYPES AND BULKY DNA ADDUCT LEVELS IN BRONCHUS
GSTM1GSTM1 GSTM1&GSTT1GSTM1&GSTT1GSTT1GSTT1SmokersSmokers Non-smokersNon-smokersSmokersSmokersNon-smokersNon-smokersSmokersSmokersNon-smokersNon-smokers
THE EFFECT OF GSTP1 Ile105Val GENOTYPEON BULKY DNA ADDUCT LEVELS IN BRONCHUS
THE EFFECT OF GSTP1 Ile105Val GENOTYPEON BULKY DNA ADDUCT LEVELS IN BRONCHUS
0
10
20
30
.
DN
A a
dd
uct
s /
108
nu
cleo
tid
es
0
10
20
30
.
DN
A a
dd
uct
s /
108
nu
cleo
tid
es
*
*
P=0.012
SmokersSmokers Non-smokersNon-smokers
MAIN CONCLUSIONSMAIN CONCLUSIONS The dose of exposure and the metabolic capacity of
the tissues influence the correlation between target
and surrogate tissue
Genetic polymorphisms of xenobiotic-metabolising
enzymes may affect the biologically effective dose of genotoxic exposure
Implications for human biomonitoring
low dose - high dose exposure surrogate - target tissue metabolic genotypes - biomarker levels
The dose of exposure and the metabolic capacity of
the tissues influence the correlation between target
and surrogate tissue
Genetic polymorphisms of xenobiotic-metabolising
enzymes may affect the biologically effective dose of genotoxic exposure
Implications for human biomonitoring
low dose - high dose exposure surrogate - target tissue metabolic genotypes - biomarker levels
PARTICIPANTS OF THE STUDYPARTICIPANTS OF THE STUDY
National Institute of Environmental Health, Budapest, HungaryBernadette Schoket
Erika Győrffy
Lívia Anna
National Center for Epidemiology, Budapest, HungaryJudit Segesdi
János Minárovits
Zoltán Győri
National Institute of Pulmonology, Budapest, HungaryIbolya Soltész
Szilárd Kostic
Attila Csekeő
National Institute of Environmental Health, Budapest, HungaryBernadette Schoket
Erika Győrffy
Lívia Anna
National Center for Epidemiology, Budapest, HungaryJudit Segesdi
János Minárovits
Zoltán Győri
National Institute of Pulmonology, Budapest, HungaryIbolya Soltész
Szilárd Kostic
Attila Csekeő